CDRD has already achieved significant results and proven its ability to have a measurable impact on innovation in Canada; effectively bolstering both academic and industrial R&D, promoting serial entrepreneurship, growing management capacity, and facilitating commercialization, company scale-up, and anchor firm establishment.
Firmly positioned as a national leader, CDRD is optimally positioned to help drive the building of Canada as a centre of global innovation. Below are just some of the measurable impacts it has made to date.
Outcomes & Impacts
CDRD is committed to training the next generation of highly-qualified personnel to drive the development of innovations. Hear more about our...Read the article
CDRD has advanced 66 potential novel drug therapies towards the clinic. Many more are in production....Read the article
CDRD has completed 14 commercial transactions including the merger of CDRD spin-off company, Kairos Therapeutics, with BC-based Zymeworks Inc. and creating...Read the article
CDRD has successfully created 7 spin-off companies including Kairos Therapeutics, Sitka Biopharma, Zucara Therapeutics, Precision Nanosystems, Immcure Therapeutics, Mesentech and Sepset...Read the article